Tymlos 80 MCG dose pen injectr 1.56ML
Ended Awarded
- Contract number
- SPE2DB25FDRCT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,351
Award facts
- Contract value 100% obligated
- $23,351.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $23,351.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Tymlos 80 microgram dose pen injectors (1.56 milliliters). The contract, issued on September 25, 2025, with an ultimate completion date of September 26, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, which is valued at $499.999 billion and extends through November 2026.
DMS Pharmaceutical Group has established itself as a key supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to secure substantial contract awards from the Defense Logistics Agency. The company's SPE2DB indefinite delivery contract enables the agency to issue firm fixed-price delivery orders for an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables supporting Department of Defense healthcare facilities worldwide. Tymlos, a human parathyroid hormone analog used to treat osteoporosis, represents one of many specialized pharmaceutical products the company delivers through this strategic partnership with the military health system.
Quick answers
Who was awarded contract SPE2DB25FDRCT?
SPE2DB25FDRCT was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FDRCT worth?
The government has obligated $23,351 on SPE2DB25FDRCT.
Is contract SPE2DB25FDRCT an order under another contract?
Yes. SPE2DB25FDRCT is a delivery order under SPE2DB24D9238, an indefinite delivery contract.
Was contract SPE2DB25FDRCT competed?
The extent of competition for SPE2DB25FDRCT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award